169 related articles for article (PubMed ID: 37344187)
1. Prevention of intrauterine adhesions.
Emingr Michal; Halaj Matúš; Malčák Michal; Hanáček Jiří
Ceska Gynekol; 2023; 88(3):210-213. PubMed ID: 37344187
[TBL] [Abstract][Full Text] [Related]
2. Restoring Fertility of Patients with Severe Asherman's Syndrome in the Office Setting: A Step-by-Step Recipe for Success.
Di Spiezio-Sardo A; De Angelis MC; Dimitrios K; Manzi A; Zizolfi B; Carugno J; Isaacson K
J Minim Invasive Gynecol; 2023 May; 30(5):355-356. PubMed ID: 36764649
[TBL] [Abstract][Full Text] [Related]
3. A comparison of intrauterine balloon, intrauterine contraceptive device and hyaluronic acid gel in the prevention of adhesion reformation following hysteroscopic surgery for Asherman syndrome: a cohort study.
Lin X; Wei M; Li TC; Huang Q; Huang D; Zhou F; Zhang S
Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):512-6. PubMed ID: 23932377
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis on the use of hyaluronic acid gel to prevent recurrence of intrauterine adhesion after hysteroscopic adhesiolysis.
Fei Z; Bin Z; Xin X; Fei H; Yuechong C
Taiwan J Obstet Gynecol; 2019 Nov; 58(6):731-736. PubMed ID: 31759520
[TBL] [Abstract][Full Text] [Related]
5. Does hyaluronic acid gel reduce intrauterine adhesions after dilation and curettage in women with miscarriage? A Multicentric randomized controlled trial (HYFACO Study).
Sroussi J; Bourret A; Pourcelot AG; Thubert T; Lesavre M; Legendre G; Tuffet S; Rousseau A; Benifla JL;
Am J Obstet Gynecol; 2022 Oct; 227(4):597.e1-597.e8. PubMed ID: 35667420
[TBL] [Abstract][Full Text] [Related]
6. Hysteroscopic Management of Asherman's Syndrome.
Khan Z; Goldberg JM
J Minim Invasive Gynecol; 2018 Feb; 25(2):218-228. PubMed ID: 29024798
[TBL] [Abstract][Full Text] [Related]
7. Secondary Prevention of Intrauterine Adhesions Following Hysteroscopic Surgery in Women With Asherman Syndrome: Is Something Better Than Nothing?
Kelley AS; Giuliani E; Schon SB
Clin Obstet Gynecol; 2020 Jun; 63(2):320-326. PubMed ID: 31815774
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting reproductive outcome of hysteroscopic adhesiolysis for Asherman's syndrome.
Yu D; Li TC; Xia E; Huang X; Liu Y; Peng X
Fertil Steril; 2008 Mar; 89(3):715-22. PubMed ID: 17681324
[TBL] [Abstract][Full Text] [Related]
9. [Secondary amenorrhea due to intrauterine adhesions: Asherman's syndrome].
Sadrzadeh S; Wamsteker K; Hummel P; Lambalk CB
Ned Tijdschr Geneeskd; 1998 Oct; 142(43):2329-32. PubMed ID: 9864508
[TBL] [Abstract][Full Text] [Related]
10. Etiology, treatment, and reproductive prognosis of women with moderate-to-severe intrauterine adhesions.
Xiao S; Wan Y; Xue M; Zeng X; Xiao F; Xu D; Yang X; Zhang P; Sheng W; Xu J; Zhou S
Int J Gynaecol Obstet; 2014 May; 125(2):121-4. PubMed ID: 24598346
[TBL] [Abstract][Full Text] [Related]
11. [Post-curettage and aspiration synechiae: is there value in an anti-adhesion agent?].
Fernandez H; Benifla JL; Fritel X; Fallet C
J Gynecol Obstet Biol Reprod (Paris); 2012 Apr; 41(2 Suppl 1):H8-12. PubMed ID: 22445169
[No Abstract] [Full Text] [Related]
12. Auto-Cross-Linked Hyaluronic Acid Gel for Prevention of Intrauterine Adhesions after Hysteroscopic Adhesiolysis: A Randomized Controlled Trial.
Zhou Q; Shi X; Saravelos S; Huang X; Zhao Y; Huang R; Xia E; Li TC
J Minim Invasive Gynecol; 2021 Feb; 28(2):307-313. PubMed ID: 32681996
[TBL] [Abstract][Full Text] [Related]
13. A matched cohort study comparing the outcome of intrauterine adhesiolysis for Asherman's syndrome after uterine artery embolization or surgical trauma.
Song D; Liu Y; Xiao Y; Li TC; Zhou F; Xia E
J Minim Invasive Gynecol; 2014; 21(6):1022-8. PubMed ID: 24842805
[TBL] [Abstract][Full Text] [Related]
14. Use of a hysteroscopic morcellator to resect miscarriage in a woman with recurrent Asherman's syndrome.
Harpham M; Abbott J
J Minim Invasive Gynecol; 2014; 21(6):1118-20. PubMed ID: 24865632
[TBL] [Abstract][Full Text] [Related]
15. Asherman's syndrome.
March CM
Semin Reprod Med; 2011 Mar; 29(2):83-94. PubMed ID: 21437822
[TBL] [Abstract][Full Text] [Related]
16. Prevention of de novo adhesion formation in patients with Asherman's syndrome.
BarboraBoudová Barbora; Lisá Zdeňka; Richtárová Adéla; Kužel D; MichalMára Michal
Ceska Gynekol; 2021; 86(4):273-278. PubMed ID: 34493053
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Adjuvant Treatment to Prevent and Treat Intrauterine Adhesions: A Network Meta-Analysis of Randomized Controlled Trials.
Yan Y; Xu D
J Minim Invasive Gynecol; 2018; 25(4):589-599. PubMed ID: 28893657
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of the use of hyaluronic acid gel to prevent intrauterine adhesions after miscarriage.
Fei Z; Xin X; Fei H; Yuechong C
Eur J Obstet Gynecol Reprod Biol; 2020 Jan; 244():1-4. PubMed ID: 31731019
[TBL] [Abstract][Full Text] [Related]
19. [Interest of auto-cross-linked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic surgery: A case-control study].
Ducarme G; Davitian C; Zarrouk S; Uzan M; Poncelet C
J Gynecol Obstet Biol Reprod (Paris); 2006 Nov; 35(7):691-5. PubMed ID: 17088770
[TBL] [Abstract][Full Text] [Related]
20. [Asherman's syndrome II--therapy, methods of guidance, prevention of readhesion processs, complications and results of therapy].
Hrazdirová L; Kužel D; Žižka Z
Ceska Gynekol; 2010 Dec; 75(6):499-506. PubMed ID: 27534004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
